PENNINGTON, N.J., March 12, 2025 /PRNewswire/ -- Zynext Ventures USA LLC (Zynext Ventures), the venture capital arm of Zydus Lifesciences (Zydus), today announced its investment in Illexcor Therapeutics (Illexcor), a pioneering biopharmaceutical company developing next-generation oral...
Hence then, the article about zynext ventures invests in illexcor therapeutics to advance novel oral therapy for sickle cell disease was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Zynext Ventures invests in Illexcor Therapeutics to advance novel oral therapy for sickle cell disease )
Also on site :
- Drew Barrymore's Buttercream-Yellow Walmart Kitchen Collection Is the Summery Refresh Your Space Needs
- Olympic Gymnastics Legend, Who Scored the World’s First Perfect 10, Relives Her Greatest Performance 50 Years Later
- ABBA’s Björn Ulvaeus Talks AI Training at United Nations Summit: Artists ‘Deserve a Place at the Table’